Literature DB >> 9888483

Blood platelets and serum VEGF in cancer patients.

P B Vermeulen, P Salven, I Benoy, G Gasparini, L Y Dirix.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9888483      PMCID： PMC2362208          DOI： 10.1038/sj.bjc.6690059

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  18 in total

Review 1.  The rationale and future potential of angiogenesis inhibitors in neoplasia.

Authors:  G Gasparini
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

2.  Clinical significance of serum levels of vascular endothelial growth factor and its receptor in biliary disease and carcinoma.

Authors:  Munechika Enjoji; Makoto Nakamuta; Koji Yamaguchi; Satoshi Ohta; Kazuhiro Kotoh; Marie Fukushima; Masami Kuniyoshi; Tomomi Yamada; Masao Tanaka; Hajime Nawata
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

3.  Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery.

Authors:  Anastasios J Karayiannakis; Konstantinos N Syrigos; Alexandros Polychronidis; Andrew Zbar; Gregory Kouraklis; Constantinos Simopoulos; Gabriel Karatzas
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

Review 4.  Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-17       Impact factor: 4.553

Review 5.  A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful?

Authors:  E Hormbrey; P Gillespie; K Turner; C Han; A Roberts; D McGrouther; A L Harris
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

6.  Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype.

Authors:  A D Blann; J S Mohan; D Bareford; G Y H Lip
Journal:  J Thromb Thrombolysis       Date:  2007-12-14       Impact factor: 2.300

7.  Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer.

Authors:  Luc Y Dirix; R Salgado; R Weytjens; C Colpaert; I Benoy; P Huget; P van Dam; A Prové; J Lemmens; P Vermeulen
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

8.  Angiogenesis is an independent prognostic factor in malignant mesothelioma.

Authors:  J G Edwards; G Cox; A Andi; J L Jones; R A Walker; D A Waller; K J O'Byrne
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

9.  Platelet release of Vascular Endothelial Growth Factor (VEGF) in patients undergoing chemotherapy for breast cancer.

Authors:  Cliona C Kirwan; Gerard J Byrne; Shant Kumar; Garry McDowell
Journal:  J Angiogenes Res       Date:  2009-10-24

10.  The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.

Authors:  Aoife J Lowery; Karl J Sweeney; Alan P Molloy; Emer Hennessy; Catherine Curran; Michael J Kerin
Journal:  BMC Cancer       Date:  2008-09-30       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.